Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C-H Lin

Showing results (641-650 of 685) with videos related to

Pageof 69
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 15, 2013
Tumoral presence of human cytomegalovirus is associated with shorter disease-free survival in elderly patients with colorectal cancer and higher levels of intratumoral interleukin-17H-P Chen, J-K Jiang, P-Y Lai, et al.
Molecular and Cellular Endocrinology|February 14, 2013
Activation of FFA1 mediates GLP-1 secretion in mice. Evidence for allosterism at FFA1Yumei Xiong, Gayathri Swaminath, Qiong Cao, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Optimization of GPR40 Agonists for Type 2 DiabetesJiwen Jim Liu, Yingcai Wang, Zhihua Ma, et al.
Plos One|November 17, 2011
AMG 837: a novel GPR40/FFA1 agonist that enhances insulin secretion and lowers glucose levels in rodentsDaniel C-H Lin, Jane Zhang, Run Zhuang, et al.
QJM : Monthly Journal of the Association of Physicians|August 10, 2020
Intravenous tissue plasminogen activator for acute ischemic stroke in patients with renal dysfunctionI-K Wang, T-H Yen, C-H Chen, et al.
ESMO Open|October 16, 2024
Survival outcomes of young-age female patients with early breast cancer: an international multicenter cohort studyJ Kim, J Kim, K H Seo, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Improving the Pharmacokinetics of GPR40/FFA1 Full AgonistsXiaohui Du, Paul J Dransfield, Daniel C-H Lin, et al.
Bioorganic & Medicinal Chemistry Letters|January 6, 2012
AMG 837: a potent, orally bioavailable GPR40 agonistJonathan B Houze, Liusheng Zhu, Ying Sun, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Aminopyrazole-Phenylalanine Based GPR142 Agonists: Discovery of Tool Compound and in Vivo Efficacy StudiesMing Yu, Mike Lizarzaburu, Alykhan Motani, et al.
Research Report (Health Effects Institute)|May 28, 2026
Monitoring and Modeling Population Exposures to Air Pollutants from Oil and Gas Development: Part 1. Predictive, Source-Oriented Modeling and Measurements to Evaluate Community Exposures to Air Pollutants and Noise from Unconventional Oil and Gas DevelopmentL Hildebrandt Ruiz, D Allen, P Misztal, et al.
Pageof 69

Showing results (641-650 of 685) with videos related to

Sort By:
Pageof 69
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 15, 2013
Tumoral presence of human cytomegalovirus is associated with shorter disease-free survival in elderly patients with colorectal cancer and higher levels of intratumoral interleukin-17H-P Chen, J-K Jiang, P-Y Lai, et al.
Molecular and Cellular Endocrinology|February 14, 2013
Activation of FFA1 mediates GLP-1 secretion in mice. Evidence for allosterism at FFA1Yumei Xiong, Gayathri Swaminath, Qiong Cao, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Optimization of GPR40 Agonists for Type 2 DiabetesJiwen Jim Liu, Yingcai Wang, Zhihua Ma, et al.
Plos One|November 17, 2011
AMG 837: a novel GPR40/FFA1 agonist that enhances insulin secretion and lowers glucose levels in rodentsDaniel C-H Lin, Jane Zhang, Run Zhuang, et al.
QJM : Monthly Journal of the Association of Physicians|August 10, 2020
Intravenous tissue plasminogen activator for acute ischemic stroke in patients with renal dysfunctionI-K Wang, T-H Yen, C-H Chen, et al.
ESMO Open|October 16, 2024
Survival outcomes of young-age female patients with early breast cancer: an international multicenter cohort studyJ Kim, J Kim, K H Seo, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Improving the Pharmacokinetics of GPR40/FFA1 Full AgonistsXiaohui Du, Paul J Dransfield, Daniel C-H Lin, et al.
Bioorganic & Medicinal Chemistry Letters|January 6, 2012
AMG 837: a potent, orally bioavailable GPR40 agonistJonathan B Houze, Liusheng Zhu, Ying Sun, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Aminopyrazole-Phenylalanine Based GPR142 Agonists: Discovery of Tool Compound and in Vivo Efficacy StudiesMing Yu, Mike Lizarzaburu, Alykhan Motani, et al.
Research Report (Health Effects Institute)|May 28, 2026
Monitoring and Modeling Population Exposures to Air Pollutants from Oil and Gas Development: Part 1. Predictive, Source-Oriented Modeling and Measurements to Evaluate Community Exposures to Air Pollutants and Noise from Unconventional Oil and Gas DevelopmentL Hildebrandt Ruiz, D Allen, P Misztal, et al.
Pageof 69